April 22, 2020
SAN DIEGO and COPENHAGEN, April 22, 2020 /PRNewswire/ — AFYX Therapeutics (“AFYX”), a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced that its Rivelin® Clobetasol patch (“Rivelin-CLO”) met the primary and multiple secondary endpoints in a Phase 2b study in patients with oral lichen planus (“OLP”). In the largest randomized, double-blind, placebo-controlled...
Do you know a young researcher who deserves recognition for their talent? Someone who impresses you, inspires you or always puts in an extra effort? Then now is the time to get writing and nominate them for the Lundbeck Foundation talent prizes and Young Investigator Prize. The deadline is 29 June 2020. Send us your...


Surge in new alcohol genes
2. June 2020
Video: Meet five professors who have devoted their brains to helping ours
14. May 2020
300 post-mortems are the cornerstone of a new Danish coronavirus project
8. May 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge